Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments. (EDUHYPER)
Status
Conditions
Details and patient eligibility
About
The primary objective is to assess the change of systolic blood pressure from baseline after a 6-month follow up for hypertensive patients initiating Viacoram® plus an educational program (NGAYDAUTIEN) in comparison to hypertensive patients initiating other antihypertensive drugs (except single pill combination).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-
Aged of at least 18 years (without upper limit of age)
-
Diagnosis of grade 1 or grade 2 hypertension
-
Naïve of treatment:
- newly diagnosed hypertension and without treatment with antihypertensive effect for at least 3 months
- previously diagnosed but without treatment with antihypertensive effect for at least 3 months
-
Patients follow-up within the scope of the current medical practice and in the same health centre during the 6-month period
Exclusion criteria
- Previously attended to the Ngay Dau Tien educational program for HBP management
- Plan to be hospitalized for other medical conditions during the next 6 months
- Plan to move/relocate during 6-month follow-up
- Have a severe disease (i.e. cirrhosis, end-stage renal disease ...)
- Are unlikely to cooperate in the study
- Arm 1: patient having contra-indication to take Viacoram® according to SmPC
- Arm 2: patient showing interest in attending NDT educational program.
Trial design
400 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal